Edward Myles
2017
In 2017, Edward Myles earned a total compensation of $1.3M as Chief Financial Officer, Executive Vice President of Finance and Treasurer at AMAG Pharmaceuticals, a 2% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $216,113 |
|---|---|
| Option Awards | $224,392 |
| Salary | $428,847 |
| Stock Awards | $402,150 |
| Other | $8,100 |
| Total | $1,279,602 |
Myles received $428.8K in salary, accounting for 34% of the total pay in 2017.
Myles also received $216.1K in non-equity incentive plan, $224.4K in option awards, $402.2K in stock awards and $8.1K in other compensation.
Rankings
In 2017, Edward Myles' compensation ranked 7,794th out of 14,666 executives tracked by ExecPay. In other words, Myles earned more than 46.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,794 out of 14,666 | 47th |
Division Manufacturing | 2,920 out of 5,772 | 49th |
Major group Chemicals And Allied Products | 950 out of 2,075 | 54th |
Industry group Drugs | 737 out of 1,731 | 57th |
Industry Pharmaceutical Preparations | 576 out of 1,333 | 57th |
Source: SEC filing on April 25, 2018.
Myles' colleagues
We found four more compensation records of executives who worked with Edward Myles at AMAG Pharmaceuticals in 2017.